Pain is an unpleasant sensory and emotional experience caused due to tissue damage or illness. It is caused due to injury and various diseases such as osteoarthritis, chronic arthritis, diabetic neuropathy, multiple sclerosis, stomach ulcer, fibromyalgia and cancer. It can be classified on the basis of duration as acute pain and chronic pain.
Acute pain is sudden onset of pain where as chronic pain persists for long periods. Chronic pain is mainly caused due to aging conditions of bone and joints and nerve damage and injury. Pain is managed by a particular set of drugs to reduce the symptoms or treat pain. Pain process is complex and there are various drugs that provide relief by acting through a variety of physiological mechanism. Opioids are the most prescribed pain medication.
These are narcotic pain medications containing natural and synthetic opiates. Opioids are usually used for acute pain, such as short-term pain after surgery. Morphine, Fentanyl, Oxycodone and Codeine are some of the opioids used for pain management.
Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/3679
North America dominates the global market for pain management drugs due to large number of aging population and favorable regulatory and healthcare reforms such as the U.S. Patient Protection and Affordable Care Act of 2010. Asia is expected to show high growth rates in the next five years in global pain management drugs market.
China and India are expected to be the fastest growing pain management drugs markets in Asia-Pacific region. Some of the key driving forces for pain management drugs market in emerging countries are increasing R&D investment, large pool of patients, increasing healthcare expenditure and rising government funding and initiatives.
In recent times there is increased use of pain management drugs due to rise in aging population. Increasing prevalence of diseases such as cancer, diabetic neuropathy, osteoarthritis and chronic arthritis, increasing number of surgical procedures and increasing healthcare expenditure are some of the key factors driving the growth for the global pain management drugs market. In addition, increasing healthcare awareness is also fuelling the growth of global pain management drugs market.
Request Customization of this Report @ https://www.persistencemarketresearch.com/request-customization/3679
However, increase in generic completion, patent expiration of blockbuster drugs and availability of substitutes such as pain relief devices are some of the major factors restraining the growth for global pain management drugs market. In addition, prescribing drug abuse would inhibit the growth of the global pain management drugs market.
Increasing R&D investment and outsourcing of pharmaceutical companies due to strong need for better treatment lead to growth in pain management drugs market in Asia. In addition, novel molecule combination and drug delivery techniques would develop opportunity for the global pain management drugs market. However, side effects of pain management drugs could lead a challenge for the global pain management drugs market.
Market Players
Some of the major companies operating in the global pain management drugs market are :
- Abbott Laboratories, Inc.,
- Pfizer, Inc.,
- Eli Lilly & Company,
- Endo Health Solutions, Inc.,
- F. Hoffmann La Roche Ltd.,
For In-depth Competitive Analysis, Pre-Book Report Now @ https://www.persistencemarketresearch.com/checkout/3679
Key geographies evaluated in this report are:
- North America
- U.S
- Canada
- Europe
- France, Germany, Italy, Spain, and the UK
- Eastern Europe
- CIS
- APAC
- China
- India
- Japan
- Australia
- Others
- Latin America
- Argentina
- Brazil
- Others
Key features of this report
- Drivers, restraints, and challenges shaping the Pain Management Drugs market dynamics
- Latest innovations and key events in the industry
- Analysis of business strategies of the top players
- Pain Management Drugs market estimates and forecasts(2015 -2021)